Using Competitor Intelligence to Navigate Global Regulatory Frameworks in Pharmaceuticals
The room was tense. A pharmaceutical executive glanced over the dense dossier, his team’s painstaking analysis of a competitor’s failed drug approval in Europe. Weeks of work had gone into predicting how the same regulatory nuances might affect their upcoming submission. One oversight, one missed insight, and millions in R&D investment could go down the …